ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,376,989, issued on Aug. 5, was assigned to Glaukos Corp. (Aliso Viejo, Calif.).
"Drug eluting ocular implants and methods of treating an ocular disorder" was invented by David S. Haffner (Mission Viejo, Calif.), Kenneth M. Curry (Oceanside, Calif.), Harold A. Heitzmann (Irvine, Calif.) and David Applegate (Laguna Hills, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled relea...